Selected Grants
Tri-Institutional Molecular Mycology and Pathogenesis Training Program
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2024 - 2029Stimulating Access to Research in Residency (StARR) - NIAID
Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2018 - 2029The Role of Inositol in Cryptococcus Biology and Pathogenesis
ResearchPrincipal Investigator · Awarded by Rutgers, The State University of New Jersey · 2024 - 2029Targeting Hsp90 in cryptococcal fungal pathogenesis
ResearchPrincipal Investigator · Awarded by University of Toronto · 2024 - 2027Interdisciplinary Research Training Program in AIDS
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2010 - 2025Genetic and Genomics Training Grant
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2020 - 2025Population Structure and Clinical Impact of Multi-strain and Mixed-species Cryptococcal Infections
ResearchCo-Principal Investigator · Awarded by National Institute of Allergy and Infectious Diseases · 2023 - 2025Advancing genomic, transcriptomic and functional approaches to combat globally important and emerging pathogens (U19)
ResearchPrincipal Investigator · Awarded by Broad Institute · 2019 - 2025Making an early diagnosis of talaromycosis - an approach to reduce morbidity and mortality in advanced HIV infection in Southeast Asia
ResearchCo Investigator · Awarded by National Institutes of Health · 2019 - 2025Host directed medicine in invasive fungal infection - HDM-FUN
Clinical TrialPrincipal Investigator · Awarded by European Union · 2020 - 2024Transplant Infectious Diseases Interdisciplinary Research Training Grant (TIDIRTG)
Inst. Training Prgm or CMEAdvisor · Awarded by National Institutes of Health · 2018 - 2024Duke CTSA (TL1) Year 5
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2018 - 2024Biosynthesis of antifungal nucleoside antibiotics
ResearchCollaborating Investigator · Awarded by National Institutes of Health · 2015 - 2024Evolution of Cryptococcus neoformans Strains from Patients with HIV/AIDS
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2011 - 2024Mapping of the IgM and IgG antibody responses to Talaromyces marneffei infection in mice and humans - Deciphering acute from reactivated or latent infections (R21)
ResearchCo Investigator · Awarded by National Institutes of Health · 2021 - 2023AM-2-19 Efficacy Testing in a Mouse Model of Cryptococcosis
ResearchPrincipal Investigator · Awarded by Sfunga Therapeutics · 2022 - 2023Development of a new class of antifungals effective against Cryptococcus
ResearchPrincipal Investigator · Awarded by Linnaeus Bioscience Inc. · 2019 - 2023Phase II, study to evaluate the safety of APX001 with Invasive mold infections caused by Aspergillus or rare mold
Clinical TrialPrincipal Investigator · Awarded by Amplyx Pharmaceuticals, Inc. · 2020 - 2023Validation of a Novel Fungicidal Approach for Cryptococcal Meningitis
ResearchCo Investigator · Awarded by Minnetronix, Inc · 2018 - 2022Mentoring Patient Oriented Research in Antibiotic-Resistant Bacteria
ResearchAdvisor · Awarded by National Institutes of Health · 2011 - 2022The Role of Host Inositol in Cryptococcus Biology and Pathogenesis
ResearchPrincipal Investigator · Awarded by Rutgers, The State University of New Jersey · 2016 - 2021Transdisciplinary Program to Identify Novel Antifungal Targets and Inhibitors
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2015 - 2021Analysis of APX2039 in Rabbit Plasma, CSF and Brain Tissue Samples
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2020 - 2020Genetics Training Grant
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 1979 - 2020APX001-201 SURGE
Clinical TrialPrincipal Investigator · Awarded by Amplyx Pharmaceuticals, Inc. · 2018 - 2020Pathobiology of C. neoformans in the Central Nervous System
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2014 - 2020Study Isavuconazole in a Rabbit Model of Cryptococcal Meningoencephalitis Caused by Cryptococccal gattii
ResearchPrincipal Investigator · Awarded by Astellas Pharma Inc. · 2017 - 2019APX001 with Fluconazole in a Murine Model of Cryptococcosis
ResearchPrincipal Investigator · Awarded by Amplyx Pharmaceuticals, Inc. · 2016 - 2019Validation of a Novel Therapeutic Approach for Cryptococcal Meningitis
ResearchCo Investigator · Awarded by Minnetronix, Inc · 2017 - 2018Mouse Study to Evaluate Efficacy of VL-2397 Against Cryptococcal Meningitis
ResearchPrincipal Investigator · Awarded by Vical, Inc. · 2018 - 2018T2 Bacteria Panel Pivotal Study
Clinical TrialPrincipal Investigator · Awarded by T2 Biosystems, Inc · 2016 - 2017Cryptococcus Neoformans
ResearchCo Investigator · Awarded by Minnetronix, Inc · 2015 - 2017Cryptococcus Infection Network Cohort study for non-HIV Patients: The CINCH Study
ResearchPrincipal Investigator · Awarded by Johns Hopkins University · 2014 - 2017Cryptococcus Neoformans
ResearchCo Investigator · Awarded by Minnetronix, Inc · 2015 - 2016Institutional Training Grant in Pediatric Infectious Disease
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2011 - 2016A Computer Modeling Approach to Create an Antifungal to Improve the Treatment of Cryptococcal Infections
ResearchPrincipal Investigator · Awarded by Amplyx Pharmaceuticals, Inc. · 2015 - 2016Evolution of Cryptococcus neoformans strains from patients with HIV/AIDS
ResearchCo Investigator · Awarded by National Institutes of Health · 2011 - 2016VTEU: Option 1-Task Area B: Protocol Development Protocol #14-0053
Clinical TrialSenior Investigator · Awarded by National Institutes of Health · 2015 - 2016Molecular Umbrella-Amphotericin B Conjugates
ResearchPrincipal Investigator · Awarded by Lehigh University · 2012 - 2016Phase I CTU Task Area A: Administrative and Overal Clinical Operations Support and Concept Development
Clinical TrialCo Investigator · Awarded by National Institutes of Health · 2014 - 2015Novel Antifungal Therapeutic Approaches
ResearchCo Investigator · Awarded by National Institutes of Health · 2001 - 2014Ras Signaling in C. neoformans virulence and development
ResearchInvestigator · Awarded by National Institutes of Health · 2008 - 2014Pulmonary Surfactant and Lung Homeostasis
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1993 - 2014Mid-Career Investigator Award: Preventing and Diagnosing Fungal Disease in Transplantation
ResearchCollaborator · Awarded by National Institutes of Health · 2007 - 2013The effects of Nlrp12 and IL-1b in inflammatory disorders
ResearchCollaborator · Awarded by National Institutes of Health · 2010 - 2012Microfluidic PCR Platform to Detect Microbial DNA
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 2005 - 2010Calcineurin and Aspergillus fumigatus Pathogenesis
ResearchMentor · Awarded by National Institutes of Health · 2004 - 2010Role of Calcineurin in Fungal Virulence
ResearchCo Investigator · Awarded by National Institutes of Health · 2004 - 2010Early Diagnosis of Neonatal Candidiasis
ResearchCo-Mentor · Awarded by National Institutes of Health · 2005 - 2009Genetic Determinants of A. Fumigatus Susceptibility
ResearchMentor · Awarded by National Institutes of Health · 2005 - 2009Host-Response relationships in patients with candidemia
ResearchMentor · Awarded by National Institutes of Health · 2002 - 2008Genetic molecular biology of virulence in C. neoformans
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1991 - 2008Prevention & dx of fungal infxns in transplantation
ResearchMentor · Awarded by National Institutes of Health · 2002 - 2007Mentored Clinical Research Scholar Program
ResearchMentor · Awarded by National Institutes of Health · 2002 - 2006Cryptococcus Neoformans - A Model for Pathogenic Fungi
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2001 - 2005Genetic Molecular Biology of Virulence in C. Neoformans
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1999 - 2004same
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1999 - 2004Cryptococcus neoformans: A model for pathogenic fungi
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1999 - 2004Same
ResearchCo Investigator · Awarded by National Institutes of Health · 1998 - 2003Ras signaling in C. neoformans virulence and development
ResearchCo Investigator · Awarded by National Institutes of Health · 2002 - 2003Same
ResearchCo Investigator · Awarded by National Institutes of Health · 1997 - 2001Genetic Molecular Biology Of Virulence In C Neoformans
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1991 - 2000Duke University Adult Aids Clinical Trails Unit
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 1996 - 1999Adult Aids Clinical Trials Unit
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 1996 - 1999Novel Antifungal Drug Targets In Cryptococcus Neoformans
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 1997 - 1999Immunosuppressant Targets In Cryptococcus Neoformans
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 1997 - 1999Genetic & Molecular Biology Of Virulence In C. Neoformans
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1991 - 1999Genetic & Molecular Biology Of Virulence In C Neoformans
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1991 - 1999Genetic And Molecular Biology Of Virulence In C Neoformans
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1993 - 1994External Relationships
- Astellas Pharma Inc.
- F2G Pharmaceutical Company
- Merck
- Pfizer Inc.
- Scynexis
- Up to Date Inc
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.